Comorbid Abetalipoproteinemia and Neurofibromatosis Type 1: Potential Clinical Implications of an Ultrarare Co-occurrence
Annals of Internal Medicine: Clinical Cases · 01.07.2026 · 5 (7)
DOI: 10.7326/aimcc.2026.0224 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Internal Medicine: Clinical Cases, erschienen am 01.07.2026. Verfasst von Yaqqira H M Womack und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research, Mayo Clinic, Phoenix, Arizona. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Research, Mayo Clinic, Phoenix, Arizona.
- Department of Clinical Genomics, Mayo Clinic, Phoenix, Arizona.
- Division of Cardiology, Mayo Clinic, Phoenix, Arizona.
- Department of Laboratory Medicine & Pathology, Mayo Clinic, Rochester, Minnesota.
Förderung
- NICHD NIH HHS
Zitieren
APA
Womack, Y. H. M., Asif, M. B., Shamoun, F. E., Baudhuin, L. M., & Osundiji, M. A. (2026). Comorbid Abetalipoproteinemia and Neurofibromatosis Type 1: Potential Clinical Implications of an Ultrarare Co-occurrence. Annals of Internal Medicine: Clinical Cases, 5(7). https://doi.org/10.7326/aimcc.2026.0224
Vancouver
Womack YHM, Asif MB, Shamoun FE, Baudhuin LM, Osundiji MA. Comorbid Abetalipoproteinemia and Neurofibromatosis Type 1: Potential Clinical Implications of an Ultrarare Co-occurrence. Annals of Internal Medicine: Clinical Cases. 2026;5(7). doi:10.7326/aimcc.2026.0224
BibTeX
@article{Womack2026,
author = {Womack, Yaqqira H M and Asif, Misha B and Shamoun, Fadi E and Baudhuin, Linnea M and Osundiji, Mayowa A},
title = {Comorbid Abetalipoproteinemia and Neurofibromatosis Type 1: Potential Clinical Implications of an Ultrarare Co-occurrence},
journal = {Annals of Internal Medicine: Clinical Cases},
year = {2026},
volume = {5},
number = {7},
doi = {10.7326/aimcc.2026.0224}
}
EUVIMED